Genome-wide analysis distinguishes hyperglycemia regulated epigenetic signatures of primary vascular cells

  1. Assam El-Osta1,2,6,7,9
  1. 1Epigenetics in Human Health and Disease Laboratory, Baker IDI Heart and Diabetes Institute, The Alfred Medical Research and Education Precinct, Melbourne, Victoria 3004, Australia;
  2. 2Epigenomic Profiling Facility, Baker IDI Heart and Diabetes Institute, The Alfred Medical Research and Education Precinct, Melbourne, Victoria 3004, Australia;
  3. 3Bioinformatics & Systems Integration, Baker IDI Heart and Diabetes Institute, The Alfred Medical Research and Education Precinct, Melbourne, Victoria 3004, Australia;
  4. 4NICTA Victoria Research Laboratory, Department of Electrical and Electronic Engineering, The University of Melbourne, Victoria 3010, Australia;
  5. 5Shanghai Cancer Institute, Jiaotong University, Shanghai 200032, China;
  6. 6Department of Pathology, The University of Melbourne, Victoria 3010, Australia;
  7. 7Faculty of Medicine, Monash University, Victoria 3800, Australia
    1. 8 These authors contributed equally to this work.

    Abstract

    Emerging evidence suggests that poor glycemic control mediates post-translational modifications to the H3 histone tail. We are only beginning to understand the dynamic role of some of the diverse epigenetic changes mediated by hyperglycemia at single loci, yet elevated glucose levels are thought to regulate genome-wide changes, and this still remains poorly understood. In this article we describe genome-wide histone H3K9/K14 hyperacetylation and DNA methylation maps conferred by hyperglycemia in primary human vascular cells. Chromatin immunoprecipitation (ChIP) as well as CpG methylation (CpG) assays, followed by massive parallel sequencing (ChIP-seq and CpG-seq) identified unique hyperacetylation and CpG methylation signatures with proximal and distal patterns of regionalization associative with gene expression. Ingenuity knowledge-based pathway and gene ontology analyses indicate that hyperglycemia significantly affects human vascular chromatin with the transcriptional up-regulation of genes involved in metabolic and cardiovascular disease. We have generated the first installment of a reference collection of hyperglycemia-induced chromatin modifications using robust and reproducible platforms that allow parallel sequencing-by-synthesis of immunopurified content. We uncover that hyperglycemia-mediated induction of genes and pathways associated with endothelial dysfunction occur through modulation of acetylated H3K9/K14 inversely correlated with methyl-CpG content.

    Footnotes

    • 9 Corresponding author.

      E-mail assam.el-osta{at}bakeridi.edu.au.

    • [Supplemental material is available for this article.]

    • Article published online before print. Article, supplemental material, and publication date are at http://www.genome.org/cgi/doi/10.1101/gr.116095.110.

    • Received October 19, 2010.
    • Accepted August 2, 2011.
    | Table of Contents

    Preprint Server